These alterations in ABCA7 have been implicated in disrupted lipid and Aβ metabolism, ultimately contributing to an increased likelihood of AD development (Aikawa et al., 2018; De Roeck et al., 2019). This evidence concerns the gene ABCA7 and Alzheimer disease.